Autoinjectors Market to look at the biggest trends hitting the industry over the coming 12 months


Rapid growth has been observed in adoption of biosimilars over branded drugs, which provides lowcost treatment options for patients.

Increase in prevalence of anaphylaxis, rise in preference among patients to choose self-administration of injection, high-end technological advancements in autoinjectors drive the growth of the market”

— Mangesh Panhale

PORTLAND, OR, UNITED STATES, October 21, 2020 / — The report on the global autoinjectors market highlights that the market is expected to reach $1.50 billion by 2019, from $5.73 billion in 2027, growing at a CAGR of 18.1% from 2020 to 2027. The report offers the current market size and forecasts along with Porter’s Five Forces analysis to help market players, stakeholders, startups, and investors to determine the current scenario and take further steps for the future. Drivers and opportunities for highest revenue generating and fastest growing segments would help in tapping into specific segment to achieve growth. Moreover, regional analysis would assist in expansion strategies for the market players and startups

Rise in prevalence of anaphylaxis, increase in preference among patients to choose self-administration of injections, and technological advancements in autoinjectors fuel the growth of the global autoinjectors market. On the other hand, availability of alternative treatment options such as general injections and oral tablets impedes the growth to some extent. However, patent expiry of biologics to fuel biosimilar demands is expected to create lucrative opportunities for the key players in the industry.

To Get the Sample Copy of Report Visit @

COVID-19 scenario-

• The outbreak of the pandemic has led to an increased demand for autoinjectors that can be used and monitored in the home environment.
• At the same time, although COVID-19 has brought effects on many aspects such as travel bans and quarantines, the restrictive measures have not been imposed on the healthcare industry, thereby leaving the global autoinjectors market unaffected.

The disposable autoinjectors segment to dominate by 2027-

Based on type, the disposable autoinjectors segment accounted for more than two-thirds of the global autoinjectors market share in 2019 and is expected to rule the roost by the end of 2027. The same segment is also anticipated to register the fastest CAGR of 18.4% throughout the forecast period. This is because the key market players are highly focused on the development of autoinjector devices.

For Purchase Enquiry @

The home care settings segment to maintain the dominant share-

Based on end user, the home care settings segment contributed to more than three-fifths of the global autoinjectors market revenue in 2019 and is anticipated to lead the trail till 2027. Simultaneously, the same segment would also manifest the fastest CAGR of 18.3% during the study period. This is due to increased patient preference for autoinjectors and rise in prevalence of anaphylaxis.

North America garnered the major share in 2019-

Based on geography, North America generated the highest share in 2019, garnering more than two-fifths of the global autoinjectors market. This is attributed to higher awareness among people, increased adoption of autoinjectors, higher number of the target population, supportive reimbursement policies, and availability of advanced devices in the region. Asia-Pacific, on the other hand, would grow at the fastest CAGR of 18.6% from 2020 to 2027.

Access Full Report @

The Major Key Players Are:

Amgen, Antares Pharma, Becton Dickinson and Company, Eli Lilly and Company, Johnson and Johnson, Mylan N.V., Novartis AG, SHL Medical, Teva Pharmaceutical Industries Ltd and Ypsomed AG.

Other Key players Are:

Biogen Idec, Owen Mumford, Consort Medical, Abbvie, and Gerresheimer.

Similar Reports:

Medical Nonwoven Disposables Market Analysis and Industry Forecast, 2027

Cancer Therapeutics Market Analysis and Industry Forecast, 2027

Medical Simulation Market Analysis and Industry Forecast, 2027

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:

Source: EIN Presswire